Zealand Pharma A/S
Homodetic cyclic peptides targeting alpha-4-beta-7 integrin
Last updated:
Abstract:
There is described herein antagonists of .alpha.4.beta.7 integrin, and more particularly cyclic peptide antagonists, such as compounds of formula (I).
Status:
Grant
Type:
Utility
Filling date:
10 May 2018
Issue date:
29 Mar 2022